Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial Jan 19, 2022
Field Trip Reveals Plans to Help Patients Access Psilocybin and MDMA Through Health Canada Jan 6, 2022
Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program… Jan 6, 2022
Ibogaine Addiction Treatments & MDMA Assisted-Psychotherapy: MINDCURE & The State Of Psychedelic Therapeutics… Nov 23, 2021
Delic Labs Applies for Dealer’s License to Commercialize Psychedelics Research, Health Exemption to Test MDMA and… Oct 6, 2021
Could MDMA Be A Frontline Therapeutic For Women’s Sexual Disorders? MINDCURE CEO Kelsey Ramsden Says Yes Sep 29, 2021
